Insider · CIK 0001536778
William Meury
Files at INCY (INCYTE CORP), SNDX (Syndax Pharmaceuticals Inc), KRTX (Karuna Therapeutics, Inc.). First filing -, latest -.
In brief
William Meury files SEC Form 4 as CEO, director and president at INCY (INCYTE CORP), and also at SNDX (Syndax Pharmaceuticals Inc), KRTX (Karuna Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; William Meury has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | INCY INCYTE CORP | AGrant or award Common Stock | +26,807 | $0.00 | $0 | 183,129 | Jul 20, 2026 |
| Jul 16, 2026 | INCY INCYTE CORP | AGrant or award Performance Sharesderivative | +80,421 | $0.00 | $0 | 80,421 | Jul 20, 2026 |
| Jul 16, 2026 | INCY INCYTE CORP | AGrant or award Employee Stock Option (right to buy)derivative | +77,148 | $0.00 | $0 | 77,148 | Jul 20, 2026 |
| Jul 2, 2026 | INCY INCYTE CORP | FTax withholding Common Stock | -4,779 | $116.86 | $558k | 156,322 | Jul 7, 2026 |
| Apr 15, 2026 | INCY INCYTE CORP | MOption exercise Common Stock | +125,000 | $0.00 | $0 | 161,101 | Apr 17, 2026 |
| Jul 2, 2025 | INCY INCYTE CORP | AGrant or award Common Stock | +36,101 | $0.00 | $0 | 36,101 | Jul 2, 2025 |
| Jul 2, 2025 | INCY INCYTE CORP | AGrant or award Performance Sharesderivative | +108,303 | $0.00 | $0 | 108,303 | Jul 2, 2025 |
| Jul 2, 2025 | INCY INCYTE CORP | AGrant or award Performance Sharesderivative | +125,000 | $0.00 | $0 | 125,000 | Jul 2, 2025 |
| Jun 26, 2025 | INCY INCYTE CORP | AGrant or award Employee Stock Option (right to buy)derivative | +110,630 | $0.00 | $0 | 110,630 | Jun 30, 2025 |
| Mar 18, 2024 | KRTX Karuna Therapeutics, Inc. | DDisposition to issuer Common Stock | -10,342 | $330.00 | $3.4M | 19,037 | Mar 18, 2024 |
| Mar 18, 2024 | KRTX Karuna Therapeutics, Inc. | DDisposition to issuer Common Stock | -19,037 | $330.00 | $6.3M | 0 | Mar 18, 2024 |
| Mar 18, 2024 | KRTX Karuna Therapeutics, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -38,688 | $330.00 | $13M | 0 | Mar 18, 2024 |
| Mar 18, 2024 | KRTX Karuna Therapeutics, Inc. | DDisposition to issuer Option (right to buy)derivative | -63,065 | $136.81 | $8.6M | 0 | Mar 18, 2024 |
| Feb 13, 2024 | KRTX Karuna Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +38,688 | $0.00 | $0 | 38,688 | Feb 15, 2024 |
| Feb 7, 2024 | SNDX Syndax Pharmaceuticals Inc | AGrant or award Common Stock | +17,000 | $0.00 | $0 | 65,000 | Feb 9, 2024 |
| Dec 28, 2023 | KRTX Karuna Therapeutics, Inc. | FTax withholding Common Stock | -8,694 | $316.30 | $2.7M | 29,379 | Dec 29, 2023 |
Questions about William Meury
Answered from the filings on this page, as of the latest one.
Is William Meury buying or selling?
William Meury has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did William Meury's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William Meury has 0.
Where does William Meury file Form 4?
William Meury has filed Form 4 at INCY (INCYTE CORP) as Chief Executive Officer; SNDX (Syndax Pharmaceuticals Inc); KRTX (Karuna Therapeutics, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.